214 related articles for article (PubMed ID: 27299)
1. Reduced nicotinamide adenine dinucleotide phosphate-dependent formation of 2,3-dihydro-2,3-dihydroxyaflatoxin B1 from aflatoxin B1 by hepatic microsomes.
Lin JK; Kennan KA; Miller EC; Miller JA
Cancer Res; 1978 Aug; 38(8):2424-8. PubMed ID: 27299
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolic conversion of aflatoxins and benzo(alpha)pyrene to nucleic acid-binding metabolites.
Gurtoo HL; Dave CV
Cancer Res; 1975 Feb; 35(2):382-9. PubMed ID: 234034
[TBL] [Abstract][Full Text] [Related]
3. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
Buckpitt AR; Bahnson LS; Franklin RB
J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the effects of pretreatment with phenobarbitone and 3-methylcholanthrene on the metabolism of aflatoxin B1 by rat liver microsomes and isolated hepatocytes in vitro.
Metcalfe SA; Colley PJ; Neal GE
Chem Biol Interact; 1981 May; 35(2):145-57. PubMed ID: 6783328
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P-450 system of rat liver.
Yoshizawa H; Uchimaru R; Kamataki T; Kato R; Ueno Y
Cancer Res; 1982 Mar; 42(3):1120-4. PubMed ID: 6800645
[TBL] [Abstract][Full Text] [Related]
6. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
Vyas KP; van Bladeren PJ; Thakker DR; Yagi H; Sayer JM; Levin W; Jerina DM
Mol Pharmacol; 1983 Jul; 24(1):115-23. PubMed ID: 6865920
[TBL] [Abstract][Full Text] [Related]
7. Aflatoxin B1 metabolism by 3-methylcholanthrene-induced hamster hepatic cytochrome P-450s.
Lai TS; Chiang JY
J Biochem Toxicol; 1990; 5(3):147-53. PubMed ID: 2126562
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
[TBL] [Abstract][Full Text] [Related]
9. The in vitro metabolism of aflatoxin B1 catalyzed by hepatic microsomes isolated from control or 3-methylcholanthrene-stimulated rats and quail.
Neal GE; Judah DJ; Green JA
Toxicol Appl Pharmacol; 1986 Mar; 82(3):454-60. PubMed ID: 3082038
[TBL] [Abstract][Full Text] [Related]
10. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
[TBL] [Abstract][Full Text] [Related]
11. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo.
Lin JK; Miller JA; Miller EC
Cancer Res; 1977 Dec; 37(12):4430-8. PubMed ID: 922734
[No Abstract] [Full Text] [Related]
12. Metabolism of aflatoxin B1 to aflatoxins Q1, M1 and P1 by mouse and rat.
Dahms R; Gurtoo HL
Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):11-20. PubMed ID: 968171
[TBL] [Abstract][Full Text] [Related]
13. Characterization of rat lung epoxide (styrene oxide) hydrase with a modified radioactive assay of improved sensitivity.
Seidegård J; DePierre JW; Moron MS; Johannesen KA; Ernster L
Cancer Res; 1977 Apr; 37(4):1075-82. PubMed ID: 402999
[TBL] [Abstract][Full Text] [Related]
14. The reactivity and carcinogenicity of aflatoxin B1-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin B1.
Swenson DH; Miller JA; Miller EC
Cancer Res; 1975 Dec; 35(12):3811-23. PubMed ID: 1104159
[TBL] [Abstract][Full Text] [Related]
15. Regioselective and stereoselective metabolisms of pyrene and 1-bromopyrene by rat liver microsomes and effects of enzyme inducers.
Shou M; Yang SK
Drug Metab Dispos; 1988; 16(2):173-83. PubMed ID: 2898329
[TBL] [Abstract][Full Text] [Related]
16. [Microsomal and photochemical oxidation of aflatoxin B1].
Sergeev BL; Bogovskiĭ SP; Veĭdebaum TI; Tanner RKh; Shevchuk IN
Eksp Onkol; 1985; 7(5):27-30. PubMed ID: 3933949
[TBL] [Abstract][Full Text] [Related]
17. Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the rat.
Mandel HG; Manson MM; Judah DJ; Simpson JL; Green JA; Forrester LM; Wolf CR; Neal GE
Cancer Res; 1987 Oct; 47(19):5218-23. PubMed ID: 2887284
[TBL] [Abstract][Full Text] [Related]
18. Protection of mitochondrial genetic system against aflatoxin B1 binding in animals resistant to aflatoxicosis.
Niranjan BG; Schaefer H; Ritter C; Avadhani NG
Cancer Res; 1986 Jul; 46(7):3637-41. PubMed ID: 3085926
[TBL] [Abstract][Full Text] [Related]
19. Aflatoxin B1-specific cytochrome P-450 isozyme (P-450-AFB) inducible by 3-methylcholanthrene in golden hamsters.
Fukuhara M; Mizokami K; Sakaguchi M; Niimura Y; Kato K; Inouye S; Takanaka A
Biochem Pharmacol; 1990 Feb; 39(3):463-9. PubMed ID: 2106321
[TBL] [Abstract][Full Text] [Related]
20. [Effect of aflatoxin B1 on monooxygenase activity in liver microsomes exposed to cytochrome P-450].
Astashkin EI; Prikhodko AZ
Vopr Pitan; 1994; (6):6-8. PubMed ID: 7732678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
